In a massive win for patients, today the Supreme Court denied petitions from 6 drugmakers — $AZN, $BMS, Janssen, $NVS, $NVO & Boehringer Ingelheim — leaving in place lower court rulings that rejected their challenges to the Medicare Drug Price Negotiation Program www.seattletimes.com/business/sup...
The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.
